These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 20851719)

  • 1. Genome-wide RNAi screens in bloodstream form trypanosomes identify drug transporters.
    Schumann Burkard G; Jutzi P; Roditi I
    Mol Biochem Parasitol; 2011 Jan; 175(1):91-4. PubMed ID: 20851719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined contribution of TbAT1 and TbMRPA to drug resistance in Trypanosoma brucei.
    Lüscher A; Nerima B; Mäser P
    Mol Biochem Parasitol; 2006 Dec; 150(2):364-6. PubMed ID: 16935360
    [No Abstract]   [Full Text] [Related]  

  • 3. Trypanosoma brucei eflornithine transporter AAT6 is a low-affinity low-selective transporter for neutral amino acids.
    Mathieu C; González Salgado A; Wirdnam C; Meier S; Grotemeyer MS; Inbar E; Mäser P; Zilberstein D; Sigel E; Bütikofer P; Rentsch D
    Biochem J; 2014 Oct; 463(1):9-18. PubMed ID: 24988048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide RNAi screens in African trypanosomes identify the nifurtimox activator NTR and the eflornithine transporter AAT6.
    Baker N; Alsford S; Horn D
    Mol Biochem Parasitol; 2011 Mar; 176(1):55-7. PubMed ID: 21093499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug resistance in human African trypanosomiasis.
    Barrett MP; Vincent IM; Burchmore RJ; Kazibwe AJ; Matovu E
    Future Microbiol; 2011 Sep; 6(9):1037-47. PubMed ID: 21958143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of Trypanosoma brucei MRPA in melarsoprol susceptibility.
    Alibu VP; Richter C; Voncken F; Marti G; Shahi S; Renggli CK; Seebeck T; Brun R; Clayton C
    Mol Biochem Parasitol; 2006 Mar; 146(1):38-44. PubMed ID: 16343658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pharmacology of adenosine transport in Trypanosoma brucei: P1/P2 revisited.
    Geiser F; Lüscher A; de Koning HP; Seebeck T; Mäser P
    Mol Pharmacol; 2005 Sep; 68(3):589-95. PubMed ID: 15933219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA-interference silencing of the adenosine transporter-1 gene in Trypanosoma evansi confers resistance to diminazene aceturate.
    Witola WH; Inoue N; Ohashi K; Onuma M
    Exp Parasitol; 2004; 107(1-2):47-57. PubMed ID: 15208037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An RNAi screen of the RRM-domain proteins of Trypanosoma brucei.
    Wurst M; Robles A; Po J; Luu VD; Brems S; Marentije M; Stoitsova S; Quijada L; Hoheisel J; Stewart M; Hartmann C; Clayton C
    Mol Biochem Parasitol; 2009 Jan; 163(1):61-5. PubMed ID: 18840477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypanosoma brucei brucei: characterization of an ODC null bloodstream form mutant and the action of alpha-difluoromethylornithine.
    Li F; Hua SB; Wang CC; Gottesdiener KM
    Exp Parasitol; 1998 Mar; 88(3):255-7. PubMed ID: 9562432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trypanosoma brucei: lack of cross-resistance to melarsoprol in vitro by cymelarsan-resistant parasites.
    Scott AG; Tait A; Turner CM
    Exp Parasitol; 1997 Jul; 86(3):181-90. PubMed ID: 9225768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple genetic mechanisms lead to loss of functional TbAT1 expression in drug-resistant trypanosomes.
    Stewart ML; Burchmore RJ; Clucas C; Hertz-Fowler C; Brooks K; Tait A; Macleod A; Turner CM; De Koning HP; Wong PE; Barrett MP
    Eukaryot Cell; 2010 Feb; 9(2):336-43. PubMed ID: 19966032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of the putative thiol conjugate transporter TbMRPA causes melarsoprol resistance in Trypanosoma brucei.
    Shahi SK; Krauth-Siegel RL; Clayton CE
    Mol Microbiol; 2002 Mar; 43(5):1129-38. PubMed ID: 11918801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TbAGO1, an argonaute protein required for RNA interference, is involved in mitosis and chromosome segregation in Trypanosoma brucei.
    Durand-Dubief M; Bastin P
    BMC Biol; 2003 Dec; 1():2. PubMed ID: 14670085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenical-resistant trypanosomes lack an unusual adenosine transporter.
    Carter NS; Fairlamb AH
    Nature; 1993 Jan; 361(6408):173-6. PubMed ID: 8421523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of choline uptake in Trypanosoma brucei procyclic and bloodstream forms.
    Macêdo JP; Schmidt RS; Mäser P; Rentsch D; Vial HJ; Sigel E; Bütikofer P
    Mol Biochem Parasitol; 2013 Jul; 190(1):16-22. PubMed ID: 23747277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Folate Transport in Antifolate Drug Action in Trypanosoma brucei.
    Dewar S; Sienkiewicz N; Ong HB; Wall RJ; Horn D; Fairlamb AH
    J Biol Chem; 2016 Nov; 291(47):24768-24778. PubMed ID: 27703008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tools for analyzing intraflagellar transport in trypanosomes.
    Julkowska D; Bastin P
    Methods Cell Biol; 2009; 93():59-80. PubMed ID: 20409811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine kinase of Trypanosoma brucei and its role in susceptibility to adenosine antimetabolites.
    Lüscher A; Onal P; Schweingruber AM; Mäser P
    Antimicrob Agents Chemother; 2007 Nov; 51(11):3895-901. PubMed ID: 17698621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Forward Genetics in African Trypanosomes.
    Hutchinson S; Glover L
    Methods Mol Biol; 2020; 2116():339-352. PubMed ID: 32221930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.